Wait For Benefits Of EudraVigilance Pilot Before Expanding To More EU Products, Says Pharma
Executive Summary
Drug companies say that any decision on taking the EudraVigilance monitoring requirements into the next phase should only be made when there is clear evidence that it has improved patient safety.